Evidence map›Paper›PMID 28847704›Full record

ArticleThe journal of sexual medicine2017

Longitudinal Patterns of Occurrence and Remission of Erectile Dysfunction in Men With Type 1 Diabetes.

Melody R Palmer, Sarah K Holt, Aruna V Sarma, Rodney L Dunn, James M Hotaling, Patricia A Cleary, Barbara H Braffett, Catherine Martin, William H Herman, Alan M Jacobson and 2 more

Open access · greenAbstract read
In one paragraph

Article in The journal of sexual medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Urologic complications in diabetes.Journal of diabetes and its complications · 2022
    Review
  5. Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study.The International journal of angiology : official publication of the International College of Angiology, Inc · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Melody R PalmerDepartment of Urology, University of Washington, Seattle, WA, USA. Electronic address: mryner@uw.edu.
Sarah K HoltDepartment of Urology, University of Washington, Seattle, WA, USA.
Aruna V SarmaDepartment of Urology, University of Michigan, Ann Arbor, MI, USA.
Rodney L DunnDepartment of Urology, University of Michigan, Ann Arbor, MI, USA.
James M HotalingDepartment of Urology, University of Utah, Salt Lake City, UT, USA.
Patricia A ClearyThe Biostatistics Center, George Washington University, Rockville, MD, USA.
Barbara H BraffettThe Biostatistics Center, George Washington University, Rockville, MD, USA.
Catherine MartinInternal Medicine, University of Michigan, Ann Arbor, MU, USA.
William H HermanInternal Medicine, University of Michigan, Ann Arbor, MU, USA; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
Alan M JacobsonResearch Institute, Winthrop University Hospital, Mineola, NY, USA.
Hunter WessellsDepartment of Urology, University of Washington, Seattle, WA, USA; Diabetes Research Center, University of Washington, Seattle, WA, USA.
Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Research Group
George Washington University · USMichigan Medicine · USUniversity of Michigan–Ann Arbor · USUniversity of Washington · USSeattle Reproductive Medicine · USUniversity of Utah · USWinthrop-University Hospital · US

Funding

Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)U01DK094157 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Ionut Bebu, Barbara Halina Braffett · 2011 to 2026
$97.6M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
Epidemiology of Diabetes Interventions and Complications Data Coordinating CenterU01DK094176 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BEBU, IONUT, BRAFFETT, BARBARA HALINA · 2012 to 2022
$30.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- DiabetesR01DK083927 · NIDDK · UNIVERSITY OF WASHINGTON · PI SARMA, ARUNA V, WESSELLS, HUNTER · 2009 to 2013
$2.7M
Multi-disciplinary Training in Benign UrologyT32DK007779 · NIDDK · UNIVERSITY OF WASHINGTON · PI WESSELLS, HUNTER · 1999 to 2016
$1.3M
NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R01 DK083927NIDDK NIH HHS T32 DK007779NIDDK NIH HHS U01 DK094157NIDDK NIH HHS U01 DK094176
6 · The paper itself

Abstract

backgroundMen with diabetes are at greater risk of erectile dysfunction (ED).

aimTo describe the natural history of ED in men with type 1 diabetes.

methodsWe examined up to 30 years of prospectively collected annual ED status and demographic and clinical variables from 600 male participants in the Diabetes Control and Complications Trial (DCCT; 1983-1993) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (1994-present; data in this study are through 2012). OUTCOMES: Yes vs no response to whether the participant had experienced impotence in the past year and whether he had used ED medication.

resultsSixty-one percent of men reported ED at least once during the study. For some men, the initial report of ED was permanent. For others, potency returned and was lost multiple times. Visual display of the data showed four longitudinal ED phenotypes: never (38.7%), isolated (6.7%), intermittent (41.8%), and persistent (12.8%). Men who never reported ED or in only 1 isolated year were younger, had lower body mass index, and better glycemic control than men in the intermittent and persistent groups at DCCT baseline. In a multivariable logistic model comparing men at their first year reporting ED, men who were older had lower odds of remission and men who were in the conventional DCCT treatment group had higher odds of remission. CLINICAL TRANSLATION: If validated in other cohorts, such findings could be used to guide individualized interventions for patients with ED. STRENGTHS AND LIMITATIONS: This is the first examination of ED with repeated measures at an annual resolution, with up to 30 years of responses for each participant. However, the yes vs no response is a limitation because the real phenotype is not binary and the question can be interpreted differently depending on the participant.

conclusionsAge, glycemic control, and BMI were important longitudinal predictors of ED. We have described a more complex ED phenotype, with variation in remission patterns, which could offer insight into different mechanisms or opportunities for intervention. If validated in other cohorts, such findings could be used to establish more accurate prognostication of outcomes for patients with ED to guide individualized interventions. Palmer MR, Holt SK, Sarma AV, et al. Longitudinal Patterns of Occurrence and Remission of Erectile Dysfunction in Men With Type 1 Diabetes. J Sex Med 2017;14:1187-1194.

Indexed as

AdultAgedDiabetes ComplicationsDiabetes Mellitus, Type 1Erectile DysfunctionFollow-Up StudiesHealth Status IndicatorsHumansLogistic ModelsMaleMiddle AgedRisk FactorsDiabetesErectile DysfunctionLongitudinal Study

Identifiers

PMID28847704
PMCPMC5624836
OpenAlexW2749273385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.